Paranovus Entertainment Technology Ltd.
NASDAQ:PAVSMedical - Pharmaceuticals
+$1.28 today
- Market cap
- $353.07M
- Beta
- -0.35
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$9.07
Volume 0.16M
Average 113.44M
PAVS Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
Paranovus Entertainment Technology Ltd.NASDAQ: PAVS
Short-term Investments · Q2 FY2025 · quarter ended Sep 2025
Short-term investments falls 82.3% from a year ago
Short-term investments stood at $4.8M at the end of Q2 FY2025, down 82.3% from a year earlier.
Context
- Short-term investments amounted to 12.9% of total assets at the end of Q2 FY2025, down 68.3 pp from a year earlier.
- Short-term investments increased in 1 of the last 3 fiscal years.
- FY2024 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether short-term investments keeps falling in the next quarterly balance sheet after a -82.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Investments history
USD · from the balance sheet
- Latest · FY2024
- 4.76M USD
- Year-over-year change
- —
| Period | Period end | Short-term Investments | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 4.76M | — |
| FY2023 | 2024-03-31 | 0 | — |
| FY2022 | 2023-03-31 | 0 | — |
| FY2021 | 2022-03-31 | 0 | — |
| FY2020 | 2021-03-31 | 0 | — |
Short-term Investments vs competitors
How PAVS compares with its peers on the latest reported figures
- PAVS's Sep 2025 short-term investments of $4.8M is the highest of the 4 companies compared; the peer median is $0.
- Short-term investments amounts to 12.9% of total assets for PAVS, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2025 | $4.8M | -82.3% | — | 12.9% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
WYHGWing Yip Food Holdings Group Limited American Depositary Shares | Mar 2026 | $0 | — | +901.1% | 0.0% |
| Peer median (excluding PAVS) | $0 | — | +901.1% | 0.0% | |
Competitors are the stored peer set for PAVS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2020 Mar 2021 | FY2021 Mar 2022 | FY2022 Mar 2023 | FY2023 Mar 2024 | FY2024 Mar 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 36.56M | 19.73M | 2.05M | 341.78K | 261.36K |
| Short-term Investments | 0 | 0 | 0 | 0 | 4.76M |
| Net Receivables | 34.56M | 29.23M | 2M | 0 | 0 |
| Inventory | 11.12M | 5.57M | 0 | 0 | 653.34K |
| Other Current Assets | 12.86M | 917.24K | 4.51M | 1.01M | 12.21K |
| Total Current Assets | 95.1M | 56.57M | 9.79M | 2.85M | 7.19M |
| Property, Plant & Equipment (Net) | 10.51M | 11.25M | 13.47K | 0 | 126.44K |
| Goodwill | 0 | 10.08M | 5.18M | 3.38M | 17.5M |
| Intangible Assets | 1.99M | 10.1M | 1.87M | 1.49M | 10.75M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 3.8M | 0 | 0 | 0 |
| Other Non-current Assets | 5.14M | 5.63M | 19.49M | 12.6K | 0 |
| Total Non-current Assets | 17.65M | 40.86M | 26.55M | 4.88M | 28.38M |
| Total Assets | 112.74M | 97.43M | 36.34M | 7.73M | 35.56M |
| Account Payables | 8.84M | 12.16M | 0 | 0 | 1.73M |
| Short-term Debt | 2.24M | 2.27M | 0 | 2.25M | 2.35M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.65M | 3.47M | 20.89M | 303.1K | 2.32M |
| Total Current Liabilities | 15.11M | 17.93M | 20.95M | 2.56M | 6.4M |
| Long-term Debt | 0 | 0 | 0 | 0 | 158.09K |
| Deferred Tax Liabilities | 0 | 2.08M | 1.51M | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 0 | 2.08M | 1.51M | 0 | 158.09K |
| Total Liabilities | 15.11M | 20.01M | 22.47M | 2.56M | 6.56M |
| Common Stock | 15.24K | 39.55K | 83.3K | 73.3K | 673.3K |
| Retained Earnings | 61.48M | 12.29M | (59.45M) | (61.96M) | (70.26M) |
| Accumulated OCI | 6.71M | 11.93M | 7.22M | 2.55M | 2.53M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 2.89M | (710.75K) | (886.01K) | (412.18K) | 4.75M |
| Total Equity | 97.64M | 77.41M | 13.87M | 5.17M | 29M |
| Total Debt | 2.24M | 2.27M | 0 | 2.25M | 2.51M |
| Net Debt | (34.32M) | (17.47M) | (2.05M) | 1.91M | 2.25M |
Paranovus Entertainment Technology Ltd.
NASDAQ:PAVS
Intrinsic Alpha fair value
Locked
Current Price
$7.02
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.